Read More 2 minute read Funding News News Therapeutics GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics Key Highlights GRO Biosciences raises $60.3M in Series B financing. Funds to advance lead program for refractory gout… byChris-Anne RoqueJuly 24, 2024